Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology

ALT

    • Home
    • ALT
ALT Biotechnology Petri Dish Reports Uncategorized

Altimmune Reports FY25 Financials: Why Is Big Pharma Staying Away

Mar 6, 2026
ALT Biotechnology Uncategorized

Altimmune prices $75M direct offering

Jan 28, 2026
mid-to-low-cap-healthcare-stocks-with-the-strongest-earnings-momentum
ALDX ALT ANVS ASRT ATNM AVNS AYTU AZTR BCAB Biotechnology CBSTF FHLC FXH IHI IYH Uncategorized VHT XLV

Mid to low cap healthcare stocks with the strongest earnings momentum

Jan 16, 2026

Comment (1) iQoncept/iStock via Getty Images As the earnings season unfolds, mid to low market...

ALT Biotechnology Uncategorized

Altimmune gains on FDA breakthrough designation for MASH therapy

Jan 5, 2026
altimmune-posts-mid-stage-trial-data-showing-antifibrotic-activity-of-lead-asset-in-mash
ALT Biotechnology Uncategorized

Altimmune posts mid-stage trial data showing antifibrotic activity of lead asset in MASH

Dec 19, 2025

magicmine/iStock via Getty Images Altimmune (ALT) on Friday announced initial results from a mid-stage trial...

  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.